质子束治疗与调强放疗在中远段食管癌患者心脏及心脏亚结构剂量学比较
该研究纳入727例接受放化疗的中远段食管癌患者,比较调强放疗(IMRT)与质子束治疗(PBT)对心脏及心脏亚结构的照射剂量。结果显示PBT较IMRT显著降低平均心脏剂量及心脏V5-V40,并降低四个心腔和四支冠状动脉的受照剂量;在PBT患者中,IMPT较PSPT进一步降低心脏V20-V40及部分心脏亚结构剂量。
要点
- PBT较IMRT显著降低平均心脏剂量及心脏V5、V10、V20、V30、V40。
- PBT较IMRT降低四个心腔和四支冠状动脉的辐射暴露。
- PBT患者中IMPT较PSPT降低心脏V20、V30、V40及部分亚结构剂量。
核心结论
- 中远段食管癌患者中,PBT较IMRT显著降低全心脏及心脏亚结构的辐射暴露。
- 需长期研究确定这种心脏保护效应对冠状动脉疾病及其他心脏并发症的影响。
研究设计与样本
- 所有患者接受50.4Gy(IMRT)或50.4钴Gray当量(PBT)放疗。
- 比较全心脏、心房、心室及四支冠状动脉的剂量体积直方图(DVH)。
- PBT患者中比较被动散射质子治疗(PSPT;n=237)与调强质子治疗(IMPT;n=13)的DVH。
主要发现
- 与IMRT相比,PBT显著降低平均心脏剂量(MHD)及心脏V5、V10、V20、V30、V40。
- 与IMRT相比,PBT降低四个心腔和四支冠状动脉的辐射暴露。
- 与PSPT相比,IMPT显著降低心脏V20、V30、V40,但未显著降低MHD、心脏V5或V10。
- IMPT较PSPT显著降低左心房、右心房、左主干冠状动脉及左回旋支动脉剂量,但未显著降低左心室、右心室、左前降支动脉或右冠状动脉剂量。
- 与较低MHD相关的因素包括PBT(P<0.001)、较小的计划靶区体积(PTV;P<0.001)及胃食管交界处(GEJ)肿瘤(P<0.001)。
临床怎么用
- 对于中远段食管癌需放化疗的患者,选择PBT可能有助于降低心脏及心脏亚结构的辐射剂量。
- 在PBT技术中,IMPT可能较PSPT进一步降低部分心脏亚结构剂量,但需结合患者具体情况选择。
局限性
- 原文未报告长期临床心脏结局,需长期研究确定心脏保护效应的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare heart and cardiac substructure radiation exposure using intensity-modulated radiotherapy (IMRT) vs. proton beam therapy (PBT) for patients with mid- to distal esophageal cancer who received chemoradiation therapy. METHODS AND MATERIALS: We identified 727 esophageal cancer patients who received IMRT (n=477) or PBT (n=250) from March 2004 to December 2015. All patients were treated to 50.4Gy with IMRT or to 50.4 cobalt Gray equivalents with PBT. IMRT and PBT dose-volume histograms (DVHs) of the whole heart, atria, ventricles, and four coronary arteries were compared. For PBT patients, passive scattering proton therapy (PSPT; n=237) and intensity-modulated proton therapy (IMPT; n=13) DVHs were compared. RESULTS: Compared with IMRT, PBT resulted in significantly lower mean heart dose (MHD) and heart V5, V10, V20, V30, and V40as well as lower radiation exposure to the four chambers and four coronary arteries. Compared with PSPT, IMPT resulted in significantly lower heart V20, V30, and V40 but not MHD or heart V5 or V10. IMPT also resulted in significantly lower radiation doses to the left atrium, right atrium, left main coronary artery, and left circumflex artery, but not the left ventricle, right ventricle, left anterior descending artery, or right coronary artery. Factors associated with lower MHD included PBT (P<0.001), smaller planning target volume (PTV; P<0.001), and gastroesophageal junction (GEJ) tumor (P<0.001). Among PBT patients, factors associated with lower MHD included IMPT (P=0.038), beam arrangement other than AP/PA (P<0.001), smaller PTV (P<0.001), and GEJ tumor (P<0.001). CONCLUSIONS: In patients with mid- to distal esophageal cancer, PBT results in significantly lower radiation exposure to the whole heart and cardiac substructures than IMRT. Long-term studies are necessary to determine how this cardiac sparing effect impacts the development of coronary artery disease and other cardiac complications.
引用
- Shiraishi Y, Xu C, Yang J, et al. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy. Radiother Oncol. 2017. PMID: 28917586. doi:10.1016/j.radonc.2017.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。